MedTrace Logo

The Need of Revisiting to an Outpatient Clinic After the Prescription of Vonoprazan or Esomeprazole

NCT04720781 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2025-05-18

No results posted yet for this study

Summary

After vonoprazan (20mg/day) or esomeprazole (20mg/day) for 4weeks is prescribed for patients with erosive esophagitis diagnosed by esophagogastroduodenoscopy, the number of patients who will visit our outpatient clinic again due to some reasons without any appointments is compared with vonoprazan group and esomeprazole.

Conditions

  • Gastroesophageal Reflux

Interventions

DRUG

Vonoprazan

Vonoprazan (20mg/day) is prescribed for 4 weeks.

DRUG

Esomeprazole

esomeprazole (20mg/day)

Sponsors & Collaborators

  • Showa Inan General Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-21
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04720781 on ClinicalTrials.gov